We have shown that CBD inhibits the growth of CR NSCLC cells via the induction of apoptosis and a parallel reduction in NRF-2 expression and increase in ROS generation in these drug-resistant cells. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.